The possible contribution of a general glycosphingolipid transporter, GM2 activator protein, to atherosclerosis

Journal of Atherosclerosis and Thrombosis

Volumn 13, Issue 6, 2006, Pages 281-285

  Yanai, Hidekatsu ^a   Yoshida, Hiroshi ^a   Tomono, Yoshiharu ^b   Tada, Norio ^a   Chiba, Hitoshi ^c  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JOSAI UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Atherogenesis; Glycosphingolipids; Macrophage; Oxidized low density lipoprotein

Indexed keywords

GANGLIOSIDE GM2 ACTIVATOR PROTEIN; GLYCOSPHINGOLIPID; LIPOPROTEIN;

ATHEROSCLEROSIS; BLOOD; HUMAN; METABOLISM; PATHOLOGY; REVIEW;

ATHEROSCLEROSIS; G(M2) ACTIVATOR PROTEIN; GLYCOSPHINGOLIPIDS; HUMANS; LIPOPROTEINS;

EID: 36549027103     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.13.281     Document Type: Review

References (37)

1. Yoshida H, Quehenberger O, Kondratenko N, Green S, and Steinberg D: Minimally oxidized low-density lipoprotein increases expression of scavenger receptor A, CD36, and macrosialin in resident mouse peritoneal macrophages. Arterioscler Thromb Vasc Biol, 1998; 18:794-802
2. Miller YI, Worrall DS, Funk CD, Feramisco JR, and Witztum JL: Actin polymerization in macrophages in response to oxidized LDL and apoptotic cells: role of 12/15-lipoxy-genase and phosphoinositide 3-kinase. Mol Biol Cell, 2003; 14:4196-4206
3. Glass CK and Witztum JL: Atherosclerosis, the road ahead. Cell, 2001; 104:503-516
4. Yanai H, Yoshida H, Fujiwara H, Yoshida S, Fuda H, Hui SP, Nagasaka H, Tada N, and Chiba H: Oxidized low-density lipoprotein upregulates GM2 activator protein gene expression. Am J Biochem & Biotech, 2005; 1:90-94
5. Meier EM, Schwarzmann G, Furst W, and Sandhoff K: The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A. J Biol Chem, 1991; 266: 1879-1887
6. Mahuran DJ: The GM2 activator protein, its roles as a co-factor in GM2 hydrolysis and as a general glycolipid transport protein. Biochim Biophys Acta, 1998; 1393:1-18
7. Garner B, Priestman DA, Stocker R, Harvey DJ, Butters TD, and Platt FM: Increased glycosphingolipid levels in serum and aortae of apolipoprotein E. gene knockout mice. J Lipid Res, 2002; 43:205-214
8. Hara A and Taketomi T: Characterization and changes of glycosphingolipids in the aorta of the Watanabe hereditable hyperlipidemic rabbit. J Biochem (Tokyo), 1991; 109:904-908
9. Mukhin DN, Chao FF, and Kruth HS: Glycosphingolipid accumulation in the aortic wall is another feature of human atherosclerosis. Arterioscler Thromb Vasc Biol, 1995; 15:1607-1615
10. Chatterjee S: Sphingolipids in atherosclerosis and vascular biology. Arterioscler Thromb Vasc Biol, 1998; 18:1523-1533
11. Bhunia AK, Han H, Snowden A, and Chatterjee S: Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells. J Biol Chem, 1997; 272:15642-15649
12. Bhunia AK, Han H, Snowden A, and Chatterjee S: Lactosylceramide stimulates Ras-GTP loading, kinases (MEK, RafD, p44 mitogen-activated protein kinase, and c-fos expression in human aortic smooth muscle cells. J Biol Chem, 1996; 271:10660-10666
13. Prokazova NV, Mikhailenko IA, and Bergelson LD: Ganglioside GM3 stimulates the uptake and processing of low density lipoproteins by macrophages. Biochem Biophys Res Commun, 1991; 177:582-587
14. Prokazova NV and Bergelson LD: Gangliosides and atherosclerosis. Lipids, 1994; 29:1-5
15. Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, and Demer LL: TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest, 1994; 93:2106-2113
16. Wen FQ, Jabbar AA, Patel DA, Kazarian T, and Valentino LA: Atherosclerotic aortic gangliosides enhance integrin-mediated platelet adhesion to collagen. Arterioscler Thromb Vasc Biol, 1999; 19:519-524
17. Bhunia AK, Schwarzmann G, and Chatterjee S: GD3 recruits reactive oxygen species to induce cell proliferation and apoptosis in human aortic smooth muscle cells. J Biol Chem, 2002; 277:16396-16402
18. Gouni-Berthold I, Seul C, Ko Y, Hescheler J, and Sachinidis A: Gangliosides GM1 and GM2 induce vascular smooth muscle cell proliferation via extracellular signal-regulated kinase 1/2 pathway. Hypertension, 2001; 38: 1030-1037
19. Bobryshev YV, Lord RS, Golovanova NK, Gracheva EV, Zvezdina ND, and Prokazova NV: Phenotype determination of anti-GM3 positive cells in atherosclerotic lesions of the human aorta. Hypothetical role of ganglioside GM3 in foam cell formation. Biochim Biophys Acta, 2001; 1535:87-99
20. Yeh LH, Kinsey AM, Chatterjee S, and Alevriadou BR: Lactosylceramide mediates shear-induced endothelial superoxide production and intercellular adhesion molecule-1 expression. J Vasc Res, 2001; 38:551-559
21. Chatterjee S and Kwiterovich PO: Glycosphingolipids of human plasma lipoproteins. Lipids, 1976; 11:462-466
22. Dawson G, Kruski AW, and Scanu AM: Distribution of glycosphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyperlipidemias. J Lipid Res, 1976; 17:125-131
23. Chatterjee S, Bell WR, and Kwiterovich PO Jr: Distribution of antithrombin III and glucosylceramide in human plasma lipoproteins and lipoprotein deficient plasma. Lipids, 1984; 19:363-366
24. Chatterjee S and Ghosh N: Oxidized low density lipoprotein stimulates aortic smooth muscle cell proliferation. Glycobiology, 1996; 6:303-311
25. Basu S and Basu M: Biosynthesis and regulation of glycosphingolipids. In: Pinto BM, Pastgheits S, Harves JW, eds. Comprehensive natural products chemistry-carbohydrates. New York, NY Pergamon Press; 1997
26. Chatterjee S, Clarke KS, and Kwiterovich PO Jr: Regulation of synthesis of lactosylceramide and long chain bases in normal and familial hypercholesterolemic cultured proximal tubular cells. J Biol Chem, 1986; 261:13474-13479
27. Chatterjee S and Castiglione E: UDPgalactose: glucosylceramide β1 → 4: galactosyltransferase activity in human proximal tubular cells from normal and familial hypercholesterolemic homozygotes. Biochim Biophys Acta, 1987; 923:136-142
28. Chatterjee S, Clarke KS, and Kwiterovich PO Jr: Uptake and metabolism of lactosylceramide on low density lipoproteins in cultured proximal tubular cells from normal and familial hypercholesterolemic homozygotes. J Biol Chem, 1986; 261:13480-13486
29. Chatterjee S, Ghosh N, Castiglione E, and Kwiterovich PO Jr: Regulation of glycosphingolipid glycosyltransferase by low density lipoprotein receptors in cultured human proximal tubular cells. J Biol Chem, 1988; 263:13017-13022
30. Glombitza GJ, Becker E, Kaiser HW, and Sandhoff K: Biosynthesis, processing, and intracellular transport of GM2 activator protein in human epidermal keratinocytes. The lysosomal targeting of the GM2 activator is independent of a mannose-6-phosphate signal. 1: J Biol Chem, 1997; 272:5199-5207
31. Wright CS, Mi LZ, and Rastinejad F: Evidence for lipid packaging in the crystal structure of the GM2-activator complex with platelet activating factor. J Mol Biol, 2004; 342:585-592
32. Wright CS, Zhao Q and Rastinejad F: Structural analysis of lipid complexes of GM2-activator protein. J Mol Biol, 2003; 331:951-964
33. Wright CS, Li SC, and Rastinejad F: Crystal structure of human GM2-activator protein with a novel beta-cup topology. J Mol Biol, 2000; 304:411-422
34. Smiljanic-Georgijev N, Rigat B, Xie B, Wang W, and Mahuran DJ: Characterization of the affinity of the G(M2) activator protein for glycolipids by a fluorescence dequenching assay. Biochim Biophys Acta, 1997; 1339:192-202
35. Hama Y, Li YT, and Li SC: Interaction of GM2 activator protein with glycosphingolipids. J Biol Chem, 1997; 272:2828-2833
36. Rigat B, Wang W, Leung A, and Mahuran DJ: Two mechanisms for the recapture of extracellular GM2 activator protein: evidence for a major secretory form of the protein. Biochemistry, 1997; 36:8325-8331
37. Mukhin DN, Prokazova NV, Bergelson LD, and Orekhov AN: Ganglioside content and composition of cells from normal and atherosclerotic human aorta. Atherosclerosis, 1989; 78:39-45